Linden Advisors’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-381,300
| Closed | -$3.91M | – | 407 |
|
|
2023
Q2 | $3.91M | Hold |
381,300
| – | – | 0.04% | 196 |
|
|
2023
Q1 | $3.86M | Hold |
381,300
| – | – | 0.04% | 204 |
|
|
2022
Q4 | $3.8M | Hold |
381,300
| – | – | 0.04% | 238 |
|
|
2022
Q3 | $3.7M | Hold |
381,300
| – | – | 0.03% | 277 |
|
|
2022
Q2 | $3.7M | Hold |
381,300
| – | – | 0.03% | 295 |
|
|
2022
Q1 | $3.7M | Buy |
+381,300
| New | +$3.7M | 0.02% | 386 |
|